GB2610722B - Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 - Google Patents

Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 Download PDF

Info

Publication number
GB2610722B
GB2610722B GB2217440.3A GB202217440A GB2610722B GB 2610722 B GB2610722 B GB 2610722B GB 202217440 A GB202217440 A GB 202217440A GB 2610722 B GB2610722 B GB 2610722B
Authority
GB
United Kingdom
Prior art keywords
cov
nitric oxide
sars
treating
releasing compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB2217440.3A
Other languages
English (en)
Other versions
GB2610722A (en
GB202217440D0 (en
Inventor
Semple Munro Hugh
Barry Wood Christopher
David Boote Nicholas
Poll Chris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thirty Respiratory Ltd
Original Assignee
Thirty Respiratory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2005987.9A external-priority patent/GB202005987D0/en
Priority claimed from GBGB2008288.9A external-priority patent/GB202008288D0/en
Application filed by Thirty Respiratory Ltd filed Critical Thirty Respiratory Ltd
Publication of GB202217440D0 publication Critical patent/GB202217440D0/en
Publication of GB2610722A publication Critical patent/GB2610722A/en
Application granted granted Critical
Publication of GB2610722B publication Critical patent/GB2610722B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GB2217440.3A 2020-04-23 2021-04-19 Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 Active GB2610722B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2005987.9A GB202005987D0 (en) 2020-04-23 2020-04-23 Methods and compositions for treating and combatting sars-cov and sars-cov-2
GBGB2008288.9A GB202008288D0 (en) 2020-06-02 2020-06-02 Methods and compositions for treating and combatting sars-cov and sars-cov-2
PCT/GB2021/050935 WO2021214440A1 (en) 2020-04-23 2021-04-19 Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2

Publications (3)

Publication Number Publication Date
GB202217440D0 GB202217440D0 (en) 2023-01-04
GB2610722A GB2610722A (en) 2023-03-15
GB2610722B true GB2610722B (en) 2024-07-31

Family

ID=75746956

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2217440.3A Active GB2610722B (en) 2020-04-23 2021-04-19 Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2

Country Status (9)

Country Link
US (1) US20240016831A1 (https=)
EP (1) EP4138795A1 (https=)
JP (1) JP2023526584A (https=)
CN (1) CN115884758A (https=)
AU (1) AU2021259360A1 (https=)
BR (1) BR112022021454A2 (https=)
CA (1) CA3180857A1 (https=)
GB (1) GB2610722B (https=)
WO (1) WO2021214440A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
ES2968200T3 (es) 2016-01-27 2024-05-08 Syk Tech Llc Aparato y métodos de aplicación tópica de óxido nítrico
EP4452219A2 (en) * 2021-12-22 2024-10-30 ConvaTec Limited Powder composition
WO2023118839A1 (en) * 2021-12-22 2023-06-29 Thirty Holdings Limited Powder composition
GB202215521D0 (en) * 2022-10-20 2022-12-07 Thirty Holdings Ltd Wound dressings
GB202302117D0 (en) * 2023-02-14 2023-03-29 Thirty Respiratory Ltd Compositions, kits and combinations
GB202302118D0 (en) * 2023-02-14 2023-03-29 Thirty Therapeutics Ltd Compositions, kits and combinations
US20260090985A1 (en) * 2024-10-02 2026-04-02 Aspire Biopharma Holdings, Inc. Oral mucosal formulations of aspirin

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
US20130028942A1 (en) * 2007-12-27 2013-01-31 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide-donating compounds and uses thereof
US20150072023A1 (en) * 2013-09-11 2015-03-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2015138406A1 (en) * 2014-03-14 2015-09-17 12th Man Technologies, Inc. Treating diseases using nitric oxide releasing solutions
WO2020245574A1 (en) * 2019-06-04 2020-12-10 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
WO2020245573A1 (en) * 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
WO2021023263A1 (zh) * 2019-08-06 2021-02-11 连云港金康和信药业有限公司 产生安全量的一氧化氮的药物组合物及其用途

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826255A (en) 1972-06-22 1974-07-30 Hudson Oxygen Therapy Sales Co Intermittent positive pressure breathing manifold
YU41046B (en) 1974-08-22 1986-10-31 Schering Ag Medicine inholating device
US4130639A (en) 1977-09-28 1978-12-19 Ethicon, Inc. Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US4268460A (en) 1977-12-12 1981-05-19 Warner-Lambert Company Nebulizer
US4253468A (en) 1978-08-14 1981-03-03 Steven Lehmbeck Nebulizer attachment
US4263907A (en) 1979-05-14 1981-04-28 Lindsey Joseph W Respirator nebulizer
US4510929A (en) 1982-04-30 1985-04-16 Bordoni Maurice E Disposable radioactive aerosol inhalation apparatus
US4649911A (en) 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
US4624251A (en) 1984-09-13 1986-11-25 Riker Laboratories, Inc. Apparatus for administering a nebulized substance
NZ241579A (en) 1991-03-25 1994-04-27 Becton Dickinson Co Antimicrobial formulations for treating the skin
US5164740A (en) 1991-04-24 1992-11-17 Yehuda Ivri High frequency printing mechanism
DK0540775T3 (da) 1991-11-07 1997-08-25 Ritzau Pari Werk Gmbh Paul Forstøver især til anvendelse i apparater til inhalationsterapi
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5558085A (en) 1993-01-29 1996-09-24 Aradigm Corporation Intrapulmonary delivery of peptide drugs
US5709202A (en) 1993-05-21 1998-01-20 Aradigm Corporation Intrapulmonary delivery of aerosolized formulations
WO1995009605A1 (en) 1993-10-06 1995-04-13 Henkel Corporation Improving phenolic disinfectant cleaning compositions with alkylpolyglucoside surfactants
US6034133A (en) 1993-11-05 2000-03-07 The University Of Virginia Patents Foundation Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
DK0746327T3 (da) 1994-02-21 2004-05-10 Univ Aberdeen Forsuret nitrit som antimikrobielt middel
GB9804469D0 (en) 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US5681802A (en) 1994-06-01 1997-10-28 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising buffering compound or compounds as potentiator of antimicrobial effectiveness
US5635462A (en) 1994-07-08 1997-06-03 Gojo Industries, Inc. Antimicrobial cleansing compositions
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
US5702754A (en) 1995-02-22 1997-12-30 Meadox Medicals, Inc. Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings
JP4484247B2 (ja) 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
ZA962455B (en) 1995-03-31 1996-10-02 B Eugene Guthery Fast acting and persistent topical antiseptic
US5758637A (en) 1995-08-31 1998-06-02 Aerogen, Inc. Liquid dispensing apparatus and methods
US5586550A (en) 1995-08-31 1996-12-24 Fluid Propulsion Technologies, Inc. Apparatus and methods for the delivery of therapeutic liquids to the respiratory system
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6083922A (en) 1996-04-02 2000-07-04 Pathogenesis, Corp. Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
EP0939618B1 (en) 1996-07-10 2002-09-11 Steris Inc. Triclosan skin wash with enhanced efficacy
US5906202A (en) 1996-11-21 1999-05-25 Aradigm Corporation Device and method for directing aerosolized mist to a specific area of the respiratory tract
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6258368B1 (en) 1997-06-04 2001-07-10 The Procter & Gamble Company Antimicrobial wipes
US5855564A (en) 1997-08-20 1999-01-05 Aradigm Corporation Aerosol extrusion mechanism
ES2175799T3 (es) 1997-10-08 2002-11-16 Sepracor Inc Forma de dosificacion para administracion en aerosol.
DK0923957T3 (da) 1997-11-19 2002-02-18 Microflow Eng Sa Dyseemne og væskedråbesprøjteindretning til en inhalator egnet til respirationsterapi
US6192876B1 (en) 1997-12-12 2001-02-27 Astra Aktiebolag Inhalation apparatus and method
US6258371B1 (en) 1998-04-03 2001-07-10 Medtronic Inc Method for making biocompatible medical article
US6103275A (en) 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
DE69912793T2 (de) 1998-07-31 2004-09-30 First Water Ltd., Marlborough Bioadhäsive Zusammensetzungen und Biomedizinische Elektroden diese enthaltend
GB2343122B (en) 1998-10-26 2003-01-08 Medic Aid Ltd Improvements in and relating to nebulisers
US6070575A (en) 1998-11-16 2000-06-06 Aradigm Corporation Aerosol-forming porous membrane with certain pore structure
US6584971B1 (en) 1999-01-04 2003-07-01 Medic-Aid Limited Drug delivery apparatus
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
JP2000355667A (ja) 1999-04-14 2000-12-26 Seiko Epson Corp カラーインクジェット記録用水系顔料インクセット、カラーインクジェット記録方法、及びカラーインクジェット記録物
US6338443B1 (en) 1999-06-18 2002-01-15 Mercury Enterprises, Inc. High efficiency medical nebulizer
US6107261A (en) 1999-06-23 2000-08-22 The Dial Corporation Compositions containing a high percent saturation concentration of antibacterial agent
EP1272243B1 (en) 2000-04-11 2005-10-26 Trudell Medical International Aerosol delivery apparatus with positive expiratory pressure capacity
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
GB0022084D0 (en) 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6601581B1 (en) 2000-11-01 2003-08-05 Advanced Medical Applications, Inc. Method and device for ultrasound drug delivery
GB0119011D0 (en) 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
GB0125222D0 (en) 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
US7066356B2 (en) 2002-08-15 2006-06-27 Ecolab Inc. Foam soap dispenser for push operation
JP4738352B2 (ja) 2004-02-09 2011-08-03 アミュレット ファーマシューティカルズ インコーポレイティッド 一酸化窒素放出ポリマー
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP1917047B1 (en) 2005-07-14 2019-09-04 First Water Limited Treatment of chronic ulcerous skin lesions
CN101028229B (zh) 2006-03-02 2012-09-05 北京富丽华德生物医药科技有限公司 基于一氧化氮的新型化妆品
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
CN101062050A (zh) 2006-04-29 2007-10-31 北京尼奥克斯生物科技有限公司 一种基于一氧化氮的新型生发产品及其制备方法
RU2008152402A (ru) 2006-05-30 2010-07-10 Дзе Дайл Корпорейшн (Us) Композиции, обладающие сильным противовирусным действием
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
GB0700911D0 (en) 2007-01-17 2007-02-28 First Water Ltd Treatment of inflammation and the complement and kinin cascades in a patient, particularly in chronic ulcerous skin lesions
GB0700908D0 (en) 2007-01-17 2007-02-28 First Water Ltd Inhibition of proteases, particularly in the treatment of chronic ulcerous skin lesions
GB0715556D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
US20130200109A1 (en) 2012-02-06 2013-08-08 Frank Yang Foaming soap dispensers and methods
CN103690490B (zh) 2012-08-23 2017-11-17 尼奥克斯(文莱)控股有限公司 基于微囊化化学试剂延时产生一氧化氮的系统和方法
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201309091D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
ES2968200T3 (es) 2016-01-27 2024-05-08 Syk Tech Llc Aparato y métodos de aplicación tópica de óxido nítrico
US11472705B2 (en) * 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
JP2023526583A (ja) * 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド 結核を治療及び抑制するための方法及び組成物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
US20130028942A1 (en) * 2007-12-27 2013-01-31 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide-donating compounds and uses thereof
US20150072023A1 (en) * 2013-09-11 2015-03-12 Advanced Inhalation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
WO2015138406A1 (en) * 2014-03-14 2015-09-17 12th Man Technologies, Inc. Treating diseases using nitric oxide releasing solutions
WO2020245574A1 (en) * 2019-06-04 2020-12-10 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
WO2020245573A1 (en) * 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
WO2021023263A1 (zh) * 2019-08-06 2021-02-11 连云港金康和信药业有限公司 产生安全量的一氧化氮的药物组合物及其用途

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Anonymous, "SaNOtize Obtains Health Canada Approval to Commence Phase II Trial for Potential COVID-19 Therapy", (2020-04-22), URL: https://www.cortellis.com/intelligence/report/ci/sourcesPressRelease/2269335, (2021-07-14), the whole document *
Anonymous,"4/07/2021 History of Changes for Study: NCT04337918_Study Record Nitric Oxide Releasing Solutions to Prevent & Treat Mild/Moderate COVID-19 Infection(NOCOVID),(2020-04-2)URL: https://clinicaltrials.gov/ct2/ history/NCT04337918?V_3=View#StudyPageTop the whole document *
Anonymous,"Nitric Oxide Releasing Solutions to Prevent & Treat Mild/Moderate COVID-19 Infection -Full Text View -ClinicalTrials Find Studies About Studies Submit Studies Resources About Site PRS (2021-02-10) URL:https://clinicialtrails.gov/ct2/show/ NCT4337918(2021-07-14) the whole document *
LISI FABIO ET AL, "Nitric Oxide to Fight Viral Infections", ADVANCED SCIENCE, vol. 8, no.7, (2021-02-09), pg 2003895, ISSN 2198-3844,:doi:10. 1002/advs.202003895, URL:https://onlinelibrary. wiley.com/doi/full-xml/10.1002/advs.202003895,The whole document, in particular table 2 *

Also Published As

Publication number Publication date
GB2610722A (en) 2023-03-15
WO2021214440A1 (en) 2021-10-28
EP4138795A1 (en) 2023-03-01
JP2023526584A (ja) 2023-06-22
CA3180857A1 (en) 2021-10-28
GB202217440D0 (en) 2023-01-04
CN115884758A (zh) 2023-03-31
BR112022021454A2 (pt) 2023-01-31
US20240016831A1 (en) 2024-01-18
AU2021259360A1 (en) 2022-12-01

Similar Documents

Publication Publication Date Title
GB2610722B (en) Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2
SI3908270T1 (sl) Kombinacija dekstrometorfana in bupropiona za zdravljenje depresije pri azijskih bolnikih
IL281999A (en) YAP/TAZ-TEAD interaction inhibitors and their use in cancer therapy
GB202106282D0 (en) Composition and use thereof
IL256052A (en) Compositions comprising a cancer stemness inhibitor and an immunotherapeutic agent for use in treating cancer
PL1846058T3 (pl) Produkt, sposób i zastosowanie go do leczenia neuropatii z wydzielaniem tlenku azotu
EP3250609A4 (en) Il13ra alpha 2 binding agents and use thereof in cancer treatment
ZA202307970B (en) Compounds for use in the treatment and prevention of covid- 19
IL295088B2 (en) Compounds and preparations for use in the treatment of skin disorders
WO2017019721A3 (en) Combinations of ezh2 inhibitors with further agents for use in the treatment of cancer
IL317571A (en) Preparations and use of TIRZEPATIDE
IL299950A (en) Superantigen conjugate for use in methods and compositions for the treatment of cancer
EP4419153A4 (en) COMPOSITION AND COMPOSITE ARTICLE FOR FORMING NITRIC OXIDE
EP4445914A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMORS AND USE
PL4326068T3 (pl) Środek odkażający i jego zastosowanie
ES3064658T3 (en) Recombinant alpha-a-crystallin and combinations for use in the treatment of cancer
PL3829553T3 (pl) Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego
EP4404944A4 (en) NITRIC OXIDE-RELEASING POLYSILOXANES AND METHODS OF PREPARATION AND USE THEREOF
IL313763A (en) Antibodies against SARS-CoV-2 SPIKE (S) and their use in the treatment of COVID-19
PL4168523T3 (pl) Kompozycje i ich zastosowanie
EP4132467A4 (en) SILVER NANOPARTICLES FOR USE IN INHIBITING AND TREATMENT OF CORONAVIRUS INFECTIONS
GB2610895B (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202019762D0 (en) Compounds for use in treatment and prophylaxis
GB202102228D0 (en) Composition and use thereof
GB202014427D0 (en) Composition and use